Solar Radiation and Human Health: 35 page chapter in a book – Feb 2013

2013, pp 529-564
Gunther Seckmeyer,
Armin Zittermann,
Richard McKenzie,
Ruediger Greinert

Solar radiation has both direct and indirect impacts on human health. Only direct effects are described here. (Space is too limited to describe the indirect effects, which are numerous, complex and imbedded into important feedback mechanisms; the most important indirect effects for human health are on the availability and quality of food, effects on aquatic and terrestrial plants and ecosystems, deterioration in air quality, damage to materials, and energy-related issues that drive the world economy.)

References

{Note: only 3 for 2010, and none since then}

1. McKinlay AF, Diffey BL (1987) A reference action spectrum for ultra-violet induced erythema in human skin. In: Passchier WF, Bosnajakovic BFM (eds) Human exposure to ultraviolet radiation: risks and regulations. Elsevier, Amsterdam, pp 83–87
2. Kerr JB, Seckmeyer G et al Surface ultraviolet radiation: past, present and future. In: Chapter 7 of Scientific assessment of ozone depletion: 2006, Global ozone research and monitoring project, report no. 50. World Meteorological Organization, Geneva
3. ICNRP/UNEP (1995) Global solar UV Index. Oberschleissheim, Germany
4. CIE (1970) Internationales Wörterbuch der Lichttechnik, Commission International de l’Éclairage, Paris
5. WMO (2007) Scientific Assessment of Ozone Depletion: 2006, vol Global ozone research and monitoring project – report no. 50. (World Meteorological Organization), Geneva
6. Bais AF, Lubin D, Coauthors: Arola A, Bernhard G, Blumthaler M, Chubarova N, Erlick C, Gies HP, Krotkov N, Lantz K, Mayer B, McKenzie RL, Piacentini RD, Seckmeyer G, Slusser JR, Zerefos CS (2007) Surface ultraviolet radiation: past, present and future. In: Albritton DL, Ajavon AN, Watson RT (eds) Chapter 7 of WMO scientific assessment of ozone depletion: 2006, Global ozone research and monitoring project, report no. 55. World Meteorological Organization, Geneva, p 58
7. UNEP (2007) Environmental effects of ozone depletion and its interactions with climate change: 2006 assessment. Photochem Photobiol Sci 6:201–332
8. Holick MF (1994) McCollum award lecture, vitamin D: new horizons for the 21st cen-tury. Am J Clin Nutr 60:619–630
9. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281
10. Hewison M, Burke F, Evans KN, Lammas DA (2007) Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103:316–321
11. Rao D, Raghuramulu N (1999) Is vitamin D redundant in an aquatic habitat? J Nutr Sci Vitaminol 45:1–8
12. Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A (1998) Vitamin D metabolism and action. Osteoporos Int 8:S13–S19
13. Hintzpeter B, Mensink G, Thierfelder W, Müller M, Scheidt-Nave C (2008) Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62:1079–1089
14. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28
15. Gorham E, Mohr S, Garland F, Garland C (2009) Vitamin D for cancer prevention and survival. Clin Rev Bone Miner Metab 7:159–175
16. Mithal A, Wahl D, Bonjour J, Burckhardt P, Dawson-Hughes B, Eisman J, El-Hajj Fuleihan G, Josse R, Lips P, Morales-Torres J, IOF Committee of Scientific Advisors (CSA) Nutrition Working Group (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20:1807–1820
17. Chris Power C, Hyppönen E (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and life-style predictors. Am J Clin Nutr 85:860–868
18. Engelsen O, Brustad M, Aksnes L, Lund E (2005) Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 81:1287–1290
19. Genuis SJ, Schwalfenberg GK, Hiltz MN, Vaselenak SA (2009) Vitamin d status of clinical practice populations at higher latitudes: analysis and applications. Int J Environ Res Public Health 6:151–173
20. Grant W (2004) Geographic variation of prostate cancer mortality rates in the United States: Implications for prostate cancer risk related to vitamin D. Int J Cancer 111:470–471
21. Kimlin MG (2008) Geographic location and vitamin D synthesis. Mol Aspects Med 29(6):453–461
22. van der Mei IAF, Ponsonby A-L, Engelsen O, Pasco JA, McGrath JJ, Eyles DW, Blizzard L, Dwyer T, Lucas R, Jones G (2007) The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 115:1132–1139
23. Bischoff-Ferrari H, Willett W, Wong J, Stuck A, Staehelin H, Orav E, Thoma A, Kiel D, Henschkowski J (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169:551–561
24. Bischoff-Ferrari H, Dawson-Hughes B, Staehelin H, Orav J, Stuck A, Theiler R, Wong J, Egli A, Kiel D, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692, <javascript:AL_get(this,%20'jour',%20'BMJ.');>
25. Zittermann A (2003) Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89:552–572
26. WHO (2008) International agency for research on cancer. Vitamin D and cancer. IARC working group reports, vol 5. WHO Press, Geneva, p 148
27. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85:1586–1591
28. Mohr S, Garland C, Gorham E, Garland F (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51:1391–1398
29. Hyppönen E (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503
30. Zipitis C, Akobeng A (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93:512–517
31. Pittas A, Lau J, Hu F, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029
32. Jorde R, Figenschau Y (2009) Supplementation with cholecalciferol does not improve glycemic control in diabtetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48:349–354
33. von Hurst P, Stonehouse W, Coad J (2009) Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr 103(4):549–555
34. Zittermann A, Koerfer R (2008) Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care 11:752–757
35. Witham M, Nadir M, Struthers A (2009) Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 27:1948–1954
36. Pilz S, Dobnig H, Nijpels G, Heine R, Stehouwer C, Snijder M, van Dam R, Dekker J (2009) Vitamin D and mortality in older men and women. Clin Endocrinol 71:666–672
37. Wang T, Pencina M, Booth S, Jacques P, Ingelsson E, Lanier K, Benjamin E, D'Agostino R, Wolf M, Vasan R (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503–511
38. Giovannucci E, Liu Y, Hollis B, Rimm E (2008) 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168:1174–1180
39. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm B, Weihrauch G, Maerz W (2008) Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168:1340–1349
40. Ginde A, Scragg R, Schwartz R, Camargo C (2009) Prospective study of serum 25-Hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57:1595–1603
41. Melamed M, Michos E, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629–1637
42. Zittermann A, Grant W (2009) 25-hydroxyvitamin D levels and all-cause mortality. Arch Intern Med 169:1075–1076
43. Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730–1737
44. Kuroda T, Shiraki M, Tanaka S, Ohta H (2009) Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone 44:168–172
45. Ng K, Meyerhardt J, Wu K, Feskanich D, Hollis B, Giovannucci E, Fuchs C (2008) Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 26:2984–2991
46. McKenzie RL, Bodeker GE, Scott G, Slusser J (2006) Geographical differences in erythemally-weighted UV measured at mid-latitude USDA sites. Photochem Photobiol Sci 5:343–352
47. Liley JB, McKenzie RL (2006) Where on Earth has the highest UV? In: UV Radiation and its effects: an update, 2006, pp. 26–37. http://www.niwa.co.nz/our-services/online-services/uv-and-ozone/workshops/2006/Liley_2.pdf
48. Seckmeyer G, Glandorf M, Wichers C, McKenzie RL, Henriques D, Carvalho F, Webb AR, Siani AM, Bais A, Kjeldstad B, Brogniez C, Werle P, Koskela T, Lakkala K, Lenoble J, Groebner J, Slaper H, denOuter PN, Feister U (2008) Europe’s darker atmosphere in the UV-B. Photochem Photobiol Sci 7:925–930. doi:10.1039/b804109a
49. McKenzie RL, Liley JB, Björn LO (2009) UV radiation: balancing risks and benefits. Photochem Photobiol 85:88–98
50. Knuschke P, Unverricht I, Ott G (2007) “Baseline reference of solar UV exposures” to assess individual UV exposure levels in the population. In: Grobner J (ed) One century of UV radiation research. PMOD, Davos pp 127–128
51. Knuschke P, Unverricht I, Ott G, Jansen M (2007) Personenbezogene messung der UV-Exposition von Arbeitnehmern im freien, Bundesanstalt fur Arbeitsschutz und Arbeitsmedian (BAUA) report no. Dortmund/Berlin/Dresden, p 195. Available from: http://www.baua.de/cae/servlet/contentblob/699494/publicationFile/46848/F1777.pdf
52. Jemal A, Ward E, Hao Y, Thun M (2005) Trends in the leading causes of death in the United States, 1970–2002. JAMA 294:1255–1259
53. Katalinic A, Kunze U, Schafer T (2003) Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 149:1200–1206
54. Diepgen TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol 146(Suppl 61):1–6
55. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130
56. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF (2001) Final version of the American joint committee on cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635–3648
57. Boyle P, Dore JF, Autier P, Ringborg U (2004) Cancer of the skin: a forgotten problem in Europe. Ann Oncol 15:5–6
58. de Vries E, Bray FI, Coebergh JW, Parkin DM (2003) Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 107:119–126
59. de Vries E, Coebergh JW (2004) Cutaneous malignant melanoma in Europe. Eur J Cancer 40:2355–2366
60. Pesch B, Ranft U, Jakubis P, Nieuwenhuijsen MJ, Hergemoller A, Unfried K, Jakubis M, Miskovic P, Keegan T (2002) Environmental arsenic exposure from a coal-burning power plant as a potential risk factor for nonmelanoma skin carcinoma: results from a case-control study in the district of Prievidza, Slovakia. Am J Epidemiol 155:798–809
61. Nindl I, Gottschling M, Stockfleth E (2007) Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 23:247–259
62. Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER, The New Hampshire Skin Cancer Study Group (2000) Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 136:1007–1011
63. Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63:8–18
64. Cleaver JE, Crowley E (2002) UV damage, DNA repair and skin carcinogenesis. Front Biosci 7:d1024–d1043
65. de Gruijl FR, van Kranen HJ, Mullenders LH (2001) UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J Photochem Photobiol B 63:9–27
66. Madan V, Hoban P, Strange RC, Fryer AA, Lear JT (2006) Genetics and risk factors for basal cell carcinoma. Br J Dermatol 154(Suppl 1):5–7
67. Norval M, Cullen AP, de Gruijl FR, Longstreth J, Takizawa Y, Lucas RM, Noonan FP, van der Leun JC (2007) The effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem Photobiol Sci 6:232–251
68. Ramos J, Villa J, Ruiz A, Armstrong R, Matta J (2004) UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Biomark Prev 13:2006–2011
69. Abdel-Malek ZA, Knittel J, Kadekaro AL, Swope VB, Starner R (2008) The melanocortin 1 receptor and the UV response of human melanocytes–a shift in paradigm. Photochem Photobiol 84:501–508
70. Besaratinia A, Pfeifer GP (2008) Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma. Hum Mutat 29:983–991
71. Dulon M, Weichenthal M, Blettner M, Breitbart M, Hetzer M, Greinert R, Baumgardt-Elms C, Breitbart EW (2002) Sun exposure and number of nevi in 5- to 6-year-old European children. J Clin Epidemiol 55:1075–1081
72. Harrison SL, MacLennan R, Buettner PG (2008) Sun exposure and the incidence of melanocytic nevi in young Australian children. Cancer Epidemiol Biomark Prev 17:2318–2324
73. Leiter U, Garbe C (2008) Epidemiology of melanoma and nonmelanoma skin cancer–the role of sunlight. Adv Exp Med Biol 624:89–103
74. Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K (2007) Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomark Prev 16:991–997
75. El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V (2009) A review of human carcinogens–part D: radiation. Lancet Oncol 10:751–752
76. International Agency for Research on Cancer Working Group (2007) The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 120:116–1122
77. Rosenstein BS, Mitchell DL (1987) Action spectra for the induction of pyrimidine(6–4)pyrimidone photoproducts and cyclobutane pyrimidine dimers in normal human skin fibroblasts. Photochem Photobiol 45:775–780
78. Cadet J, Anselmino C, Douki T, Voituriez L (1992) Photochemistry of nucleic acids in cells. J Photochem Photobiol B 15:277–298
79. Cadet J, Sage E, Douki T (2005) Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 571:3–17
80. Douki T, Court M, Sauvaigo S, Odin F, Cadet J (2000) Formation of the main UV-induced thymine dimeric lesions within isolated and cellular DNA as measured by high performance liquid chromatography-tandem mass spectrometry. J Biol Chem 275:11678–11685
81. Mitchell DL, Brash DE, Nairn RS (1990) Rapid repair kinetics of pyrimidine(6–4)pyrimidone photoproducts in human cells are due to excision rather than conformational change. Nucleic Acids Res 18:963–971
82. Mitchell DL (2006) Quantification of photoproducts in mammalian cell DNA using radioimmunoassay. Method Mol Biol 314:239–249
83. Greinert R, Boguhn O, Harder D, Breitbart EW, Mitchell DL, Volkmer B (2000) The dose dependence of cyclobutane dimer induction and repair in UVB-irradiated human keratinocytes. Photochem Photobiol 72:701–708
84. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei Q (2007) Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res 13:6532–6539
85. Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q (2005) In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst 97:1822–1831
86. Wei Q, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Strom SS, Wang LE, Guo Z, Qiao Y, Amos CI, Spitz MR, Duvic M (2003) Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 95:308–315
87. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L (1993) Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci U S A 90:10529–10533
88. Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK, Yamasaki H (1994) UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci U S A 91:360–364
89. Ravanat JL, Douki T, Cadet J (2001) Direct and indirect effects of UV radiation on DNA and its components. J Photochem Photobiol 63:88–102
90. Sage E, Lamolet B, Brulay E, Moustacchi E, Chteauneuf A, Drobetsky EA (1996) Mutagenic specificity of solar UV light in nucleotide excision repair-deficient rodent cells. Proc Natl Acad Sci U S A 93:176–180
91. Besaratinia A, Kim SI, Pfeifer GP (2008) Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells. FASEB J 22:2379–2392
92. Ikehata H, Kudo H, Masuda T, Ono T (2003) UVA induces C–>T transitions at methyl-CpG-associated dipyrimidine sites in mouse skin epidermis more frequently than UVB. Mutagenesis 18:511–519
93. Runger TM, Kappes UP (2008) Mechanisms of mutation formation with long-wave ultraviolet light (UVA). Photodermatol Photoimmunol Photomed 24:2–10
94. Mouret S, Baudouin C, Charveron M, Favier A, Cadet J, Douki T (2006) Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci U S A 103:13765–13770
95. Matsumura Y, Ananthaswamy HN (2002) Molecular mechanisms of photocarcinogenesis. Front Biosci 7:d765–d783
96. Cruet-Hennequart S, Gallagher K, Sokol AM, Villalan S, Prendergast AM, Carty MP (2010) DNA Polymerase eta, a key protein in translesion synthesis in human cells. Subcell Biochem 50:189–209
97. Hendel A, Ziv O, Gueranger Q, Geacintov N, Livneh Z (2008) Reduced efficiency and increased mutagenicity of translesion DNA synthesis across a TT cyclobutane pyrimidine dimer, but not a TT 6–4 photoproduct, in human cells lacking DNA polymerase eta. DNA Repair Amst 7:1636–1646
98. Hussain SP, Hollstein MH, Harris CC (2000) p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment. Ann NY Acad Sci 919:79–85
99. Benjamin CL, Ullrich SE, Kripke ML, Ananthaswamy HN (2008) p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem Photobiol 84:55–62
100. Brash DE (2006) Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol 154(Suppl 1):8–10
101. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ (1996) Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1:136–142
102. Nelson MA, Einspahr JG, Alberts DS, Balfour CA, Wymer JA, Welch KL, Salasche SJ, Bangert JL, Grogan TM, Bozzo PO (1994) Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 85:23–29
103. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash DE (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A 90:4216–4220
104. Brash DE (1997) Sunlight and the onset of skin cancer. Trends Genet 13:410–414
105. Fusenig NE, Boukamp P (1998) Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 23:144–158
106. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR, Ye K, Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, Mudie LJ, Ning Z, Royce T, Schulz-Trieglaff OB, Spiridou A, Stebbings LA, Szajkowski L, Teague J, Williamson D, Chin L, Ross MT, Campbell PJ, Bentley DR, Futreal PA, Stratton MR (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463:191–196
107. Benjamin CL, Melnikova VO, Ananthaswamy HN (2008) P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 624:265–282
108. Bosserhoff AK (2006) Novel biomarkers in malignant melanoma. Clin Chim Acta 367:28–35
109. Daya-Grosjean L, Couve-Privat S (2005) Sonic hedgehog signaling in basal cell carcinomas. Cancer Lett 225:181–192
110. Hussein MR (2005) Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol 32:191–205
111. Lupi O (2007) Correlations between the sonic Hedgehog pathway and basal cell carcinoma. Int J Dermatol 46:1113–1117
112. Sekulic A, Haluska P Jr, Miller AJ, Genebriera DL, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic SN (2008) Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc 83:825–846
113. Dahl C, Guldberg P (2007) The genome and epigenome of malignant melanoma. APMIS 115:1161–1176
114. Faurschou A, Haedersdal M, Poulsen T, Wulf HC (2007) Squamous cell carcinoma induced by ultraviolet radiation originates from cells of the hair follicle in mice. Exp Dermatol 16:485–489
115. Gerdes MJ, Yuspa SH (2005) The contribution of epidermal stem cells to skin cancer. Stem Cell Rev 1:225–231
116. Greinert R (2009) Skin cancer: new markers for better prevention. Pathobiology 76:64–81
117. Grichnik JM (2008) Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol 128:2365–2380
118. Schwabe M, Lubbert M (2007) Epigenetic lesions in malignant melanoma. Curr Pharm Biotechnol 8:382–387
119. Yan X, Owens DM (2008) The skin: a home to multiple classes of epithelial progenitor cells. Stem Cell Rev 4:113–118
120. Zabierowski SE, Herlyn M (2008) Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 26:2890–2894
121. Muller HK, Malley RC, McGee HM, Scott DK, Wozniak T, Woods GM (2008) Effect of UV radiation on the neonatal skin immune system- implications for melanoma. Photochem Photobiol 84:47–54
122. Amerio P, Carbone A, Auriemma M, Varrati S, Tulli A (2009) UV induced skin immunosuppression. Anti-Infamm Anti-Allergy Agents Med Chem 8:3–13
123. Norval M (2000) The impact of ultraviolet radiation on immune response. Radiat Prot Dosim 91:51–56
124. Shimizu T, Streilein JW (1994) Local and systemic consequences of acute, low-dose ultraviolet B radiation are mediated by different immune regulatory mechanisms. Eur J Immunol 24:1765–1770
125. Noonan FP, De Fabo EC (1992) Immunosuppression by ultraviolet B radiation: initiation by urocanic acid. Immunol Today 13:250–254
126. Kaneko K, Smetana-Just U, Matsui M, Young AR, John S, Norval M, Walker SL (2008) cis-Urocanic acid initiates gene transcription in primary human keratinocytes. J Immunol 181:217–224
127. Kurimoto I, Streilein JW (1992) cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. J Immunol 148:3072–3078
128. Kondo S, Sauder DN, McKenzie RC, Fujisawa H, Shivji GM, El Ghorr A, Norval M (1995) The role of cis-urocanic acid in UVB-induced suppression of contact hypersensitivity. Immunol Lett 48:181–186
129. el Ghorr AA, Norval M (1995) A monoclonal antibody to cis-urocanic acid prevents the ultraviolet-induced changes in Langerhans cells and delayed hypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity responses. J Invest Dermatol 105:264–268
130. Kuchel JM, Barnetson RS, Halliday GM (2005) Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans. Photochem Photobiol Sci 4:577–582
131. Yarosh DB (2002) Enhanced DNA repair of cyclobutane pyrimidine dimers changes the biological response to UV-B radiation. Mutat Res 509:221–226
132. Vink AA, Strickland FM, Bucana C, Cox PA, Roza L, Yarosh DB, Kripke ML (1996) Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J Exp Med 183:1491–1500
133. Tommasi S, Swiderski PM, Tu Y, Kaplan BE, Pfeifer GP (1996) Inhibition of transcription factor binding by ultraviolet-induced pyrimidine dimers. Biochemistry 35:15693–15703
134. Kripke ML, Cox PA, Alas LG, Yarosh DB (1992) Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci U S A 89:7516–7520
135. Donawho CK, Muller HK, Bucana CD, Kripke ML (1996) Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms. J Immunol 157:781–786
136. Ullrich SE (1995) Modulation of immunity by ultraviolet radiation: key effects on antigen presentation. J Invest Dermatol 105:30S–36S
137. Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD (1991) Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J Immunol 146:485–491
138. Shreedhar V, Giese T, Sung VW, Ullrich SE (1998) A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 160:3783–3789
139. Ullrich SE (1996) Does exposure to UV radiation induce a shift to a Th-2-like immune reaction? Photochem Photobiol 64:254–258
140. Clement-Lacroix P, Michel L, Moysan A, Morliere P, Dubertret L (1996) UVA-induced immune suppression in human skin: protective effect of vitamin E in human epidermal cells in vitro. Br J Dermatol 134:77–84
141. Rana S, Rogers LJ, Halliday GM (2010) Immunosuppressive ultraviolet-A radiation inhibits the development of skin memory CD8 T cells. Photochem Photobiol Sci 9:25–30
142. Seite S, Zucchi H, Moyal D, Tison S, Compan D, Christiaens F, Gueniche A, Fourtanier A (2003) Alterations in human epidermal Langerhans cells by ultraviolet radiation: quantitative and morphological study. Br J Dermatol 148:291–299
143. Stoebner PE, Poosti R, Djoukelfit K, Martinez J, Meunier L (2007) Decreased human epidermal antigen-presenting cell activity after ultraviolet A exposure: dose-response effects and protection by sunscreens. Br J Dermatol 156:1315–1320
144. Christophers E (2001) Psoriasis–epidemiology and clinical spectrum. Clin Exp Dermatol 26:314–320
145. Krueger JG (2002) The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 46:1–23
146. Traub M, Marshall K (2007) Psoriasis–pathophysiology, conventional, and alternative approaches to treatment. Altern Med Rev 12:319–330
147. Barker JN (2001) Genetic aspects of psoriasis. Clin Exp Dermatol 26:321–325
148. Valdimarsson H (2007) The genetic basis of psoriasis. Clin Dermatol 25:563–567
149. Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A (2005) Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol 52:660–670
150. Lim JL, Stern RS (2005) High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol 124:505–513
151. Nijsten TE, Stern RS (2003) The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study. J Invest Dermatol 121:252–258
152. Stern RS, Bolshakov S, Nataraj AJ, Ananthaswamy HN (2002) p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization. J Invest Dermatol 119:522–526
153. Stern RS, Liebman EJ, Vakeva L (1998) Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst 90:1278–1284
154. Peritz AE, Gasparro FP (1999) Psoriasis, PUVA, and skin cancer–molecular epidemiology: the curious question of T–>A transversions. J Investig Dermatol Symp Proc 4:11–16
155. Wuttke S, Seckmeyer G, Konig-Langlo G (2006) Measurements of spectral snow albedo at Neumayer, Antarctica. Annles Geophysicae 24:7–21
156. DIN (2008) German Institute for Normalisation Report – Several papers, ISBN 978-3-410-16938. In: 2. DIN Expertenforum, Wirkung des Lichts auf Menschen, Beuth, Berlin, p 43
157. Schmidt C, Collette F, Leclercq Y, Sterpenich V, Vandewalle G, Berthomier P, Berthomier C, Phillips C, Tinguely G, Darsaud A, Gais S, Schabus M, Desseilles M, Dang-Vu TT, Salmon E, Balteau E, Degueldre C, Luxen A, Maquet P, Cajochen C, Peigneux P (2009) Homeostatic sleep pressure and responses to sustained attention in the suprachiasmatic area Science 465:516–519
158. Kligman LH (1982) Intensification of ultraviolet-induced dermal damage by infrared radiation. Arch Dermatol Res 272:229–267
159. Zastrow L, Groth N (2008) The missing link – light-induced (280–1600 nm) free radical formation in human skin. Skin Pharmacol Physiol 22:31–44
160. Gebbers N, Hirt-Burri N (2007) Water-filtered infrared-a radiation (wira) is not implicated in cellular degeneration of human skin. GMS Ger Med Sci 5:1–14
161. Menendez S, Coulomb B (1998) Non-coherent near infrared radiation protects normal human dermal fibroplasts from solar ultraviolet toxicity. J Investig Dermatol 111:629–633
162. Schieke SM, Stege H (2002) Infrared-a radiation-induced matrix metalloproteinase 1 expression is mediated through exracellular signal-regulated kinase 1/2 activation in human dermal fibroblasts. J Investig Dermatol 119:1323–1329
163. Jantschitsch C, Majewski S (2009) Infrared radiation confers resistanse to uv-induces apoptosus via reduction of DNA damage and upregulation of antiapoptotic proteins. Soc Investig Dermatol 129:1271–1279
164. Modell J, Rosenthal N, Harriett A, Krishen A, Asgharian A, Foster V, Metz A, Rockett C, Wightman D (2005) Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL biological psychiatry. Biol Psychiatry 58:658–667
165. Pissulla D, Seckmeyer G, Cordero RR, Blumthaler M, Schallhart B, Webb A, Kifte ASR, Bais AF, Kouremeti N, Cede A, Herman J, Kowalewski M (2009) Comparison of different calibration methods to derive spectral radiance as a function of incident and azimuth angle. Photochem Photobiol Sci 8:516–527
166. WMO (1983) Guide to meteorological instruments and methods of observation (Fifth edn), World Meteorological Organization, Report No. 8, Geneva